Labcorp Announces 2024 Fourth Quarter and Full Year Results

Company Provides 2025 Guidance Results from Continuing Operations versus last year: Revenue: Q4 of $3.33 billion vs$3.03 billion; Full year of $13.01 billion vs$12.16 billion Diluted EPS: Q4 of $1.70 vs$(1.95); Full year of $8.84 vs$4.33 Adjusted EPS: Q4 of $3.45 vs$3.30; Full year of $14.57 vs$13.56 Free Cash Flow: Q4 of $665.1 million vs$412.4 million; Full year of $1.10 billion vs$748.7 million Announced 10 transactions and launched new innovative tests meeting significant unmet medical needs ...